Brenner Malcolm
Known title: DirectorCIK: 0001818068
Associated companies
Transaction History
| KLRS | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 | View on chart |
| KLRS | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 | View on chart |
| KLRS | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 | View on chart |
| KLRS | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI
Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.